Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Fischer

Showing results (251-260 of 323) with videos related to

Pageof 33
Sort By:
Plos One|August 16, 2016
Influence of Ocean Acidification on a Natural Winter-to-Summer Plankton Succession: First Insights from a Long-Term Mesocosm Study Draw Attention to Periods of Low Nutrient ConcentrationsLennart T Bach, Jan Taucher, Tim Boxhammer, et al.
Cancer Cell|December 18, 2014
The risk-associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiationGaurav Kumar Pandey, Sanhita Mitra, Santhilal Subhash, et al.
Klinische Padiatrie|June 5, 2025
Correction: GPOH Guidelines for Diagnosis and First-line Treatment of Patients with Neuroblastic Tumors, update 2025Thorsten Simon, Theresa Thole, Sveva Castelli, et al.
Klinische Padiatrie|May 9, 2025
GPOH Guidelines for Diagnosis and First-line Treatment of Patients with Neuroblastic Tumors, update 2025Thorsten Simon, Theresa Thole, Sveva Castelli, et al.
Allergo Journal : Interdisziplinare Zeitschrift Fur Allergologie Und Umweltmedizin : Organ Der Deutschen Gesellschaft Fur Allergie- Und Immunitatsforschung|February 22, 2021
Johannes Ring, Kirsten Beyer, Tilo Biedermann, et al.
Journal of Personalized Medicine|August 27, 2021
Neuroblastoma Risk Assessment and Treatment Stratification with Hybrid Capture-Based Panel SequencingAnnabell Szymansky, Louisa-Marie Kruetzfeldt, Lukas C Heukamp, et al.
Cancer Research Communications|January 6, 2025
Serially Quantifying TERT Rearrangement Breakpoints in ctDNA Enables Minimal Residual Disease Monitoring in Patients with NeuroblastomaJan F Hollander, Annabell Szymansky, Jasmin Wünschel, et al.
British Journal of Cancer|February 22, 2023
Genomic ALK alterations in primary and relapsed neuroblastomaCarolina Rosswog, Jana Fassunke, Angela Ernst, et al.
Cancer Research|January 15, 2014
GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3Johannes Fabian, Marco Lodrini, Ina Oehme, et al.
The EMBO Journal|November 11, 2024
METTL3/MYCN cooperation drives neural crest differentiation and provides therapeutic vulnerability in neuroblastomaKetan Thombare, Roshan Vaid, Perla Pucci, et al.
Pageof 33

Showing results (251-260 of 323) with videos related to

Sort By:
Pageof 33
Plos One|August 16, 2016
Influence of Ocean Acidification on a Natural Winter-to-Summer Plankton Succession: First Insights from a Long-Term Mesocosm Study Draw Attention to Periods of Low Nutrient ConcentrationsLennart T Bach, Jan Taucher, Tim Boxhammer, et al.
Cancer Cell|December 18, 2014
The risk-associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiationGaurav Kumar Pandey, Sanhita Mitra, Santhilal Subhash, et al.
Klinische Padiatrie|June 5, 2025
Correction: GPOH Guidelines for Diagnosis and First-line Treatment of Patients with Neuroblastic Tumors, update 2025Thorsten Simon, Theresa Thole, Sveva Castelli, et al.
Klinische Padiatrie|May 9, 2025
GPOH Guidelines for Diagnosis and First-line Treatment of Patients with Neuroblastic Tumors, update 2025Thorsten Simon, Theresa Thole, Sveva Castelli, et al.
Allergo Journal : Interdisziplinare Zeitschrift Fur Allergologie Und Umweltmedizin : Organ Der Deutschen Gesellschaft Fur Allergie- Und Immunitatsforschung|February 22, 2021
Johannes Ring, Kirsten Beyer, Tilo Biedermann, et al.
Journal of Personalized Medicine|August 27, 2021
Neuroblastoma Risk Assessment and Treatment Stratification with Hybrid Capture-Based Panel SequencingAnnabell Szymansky, Louisa-Marie Kruetzfeldt, Lukas C Heukamp, et al.
Cancer Research Communications|January 6, 2025
Serially Quantifying TERT Rearrangement Breakpoints in ctDNA Enables Minimal Residual Disease Monitoring in Patients with NeuroblastomaJan F Hollander, Annabell Szymansky, Jasmin Wünschel, et al.
British Journal of Cancer|February 22, 2023
Genomic ALK alterations in primary and relapsed neuroblastomaCarolina Rosswog, Jana Fassunke, Angela Ernst, et al.
Cancer Research|January 15, 2014
GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3Johannes Fabian, Marco Lodrini, Ina Oehme, et al.
The EMBO Journal|November 11, 2024
METTL3/MYCN cooperation drives neural crest differentiation and provides therapeutic vulnerability in neuroblastomaKetan Thombare, Roshan Vaid, Perla Pucci, et al.
Pageof 33